A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering ... Dec. 13, 2024 — Microorganisms produce a wide variety of natural products that can be ...

ZUG, Switzerland and BOSTON, March 26, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

CRISPR Therapeutics' shares are down by 41% ... that could drive long-term returns for your portfolio. Companies in the space often focus on the research and development of cutting-edge ...

This study designs a DNA logic gate system integrating nucleic acid aptamers, catalytic hairpin assembly (CHA), and CRISPR-Cas12a, pioneering its use for AML antigen detection. The system comprises ...

An enhanced CRISPR tool, CRISPR-Cas12a, has been developed to enable simultaneous assessment of multiple genetic changes, improving disease modeling and gene editing.

CRISPR-Cascade, including sample preparation, requires about half an hour, making it the fastest available bloodstream infection diagnostic. There is also the potential to improve sample prep ...